|
|
||||||||
Baylor College of Medicine, Houston, Texas and the Methodist Hospital
Correspondence: For reprints contact: Philip C. Johnson, Dept. of Internal Medicine, Baylor College of Medicine, Texas Medical Center, Houston, Tex. 77025.
ABSTRACT
A comparison between radiocontrast and radionuclide angiography was made in 272 patients with cerebrovascular disease. The radionuclide studies showed a 58% true-positive rate and 11% false-positive rate. The true-positive rate for patients with unilateral carotid artery disease was 66%. These results were similar to those of other reported series (63% true positive and 11% false positive). Therefore, radionuclide angiography is not recommended as the major screening procedure in cerebrovascular disease.
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| JOURNAL OF NUCLEAR MEDICINE TECHNOLOGY | THE JOURNAL OF NUCLEAR MEDICINE |